CRC tumor tissues were divided into 2 groups: 25 CRC patients with BRAF-mutant and 25 CRC patients without BRAF mutation, and the clinicopathological features of the patients are described in Table 1. The gene discussed is BRAF; the disease is colorectal carcinoma.